Par Drugs and Chemicals Limited has changed its statutory auditor to M/s. Sarupria Somani & Associates for the financial year 2024-25, subject to approval at the upcoming AGM. The company also plans to acquire land for a new R&D lab at a cost of approximately Rs 12 crore.